NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
NORTHWEST BIOTHERAPEUTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $254.79M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Northwest Biotherapeutics has not reported a dividend
No dividend per share appears in Northwest Biotherapeutics's annual filings since fiscal 2010.